Company:  ESCALON MEDICAL CORP (ESMC)
Form Type:  10-K
Filing Date:  9/28/2007 
CIK:  0000862668 
Address:  435 DEVON PARK ROAD
SUITE 824
 
City, State, Zip:  WAYNE, Pennsylvania 19087 
Telephone:  (610) 688-6830 
Fiscal Year:  06/30 
Last Trade
Last Trade: 
$0.08  
Change: 
0.00 (0.00%)  
Trade Time: 
Mar 20  
Market Cap: 
$0.57M
Trade ESMC now with 

© 2023  
Description of Business
Escalon Medical Corp. ("Escalon" or "Company") is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the "Company" collectively shall mean Escalon, which includes its division called "Trek" and its wholly owned subsidiaries: Sonomed, Inc. ("Sonomed"), Escalon Digital Solutions, Inc. ("EMI"), and Sonomed IP Holdings, Inc. All intercompany accounts and transactions have been eliminated. The Company dissolved two other inactive entities, Escalon Holding, Inc. ("EHI"), and Escalon IP Holdings Inc. in a tax-free dissolution under Section 332 of the Internal Revenue Code in the year ended June 30, 2021. The Company operates in the healthcare market, specializing in the development, manufacture, marketing and distribution of medical devices for ophthalmic applications.
Register and access this filing in:     
  FORM 10-K
    PART 1
      ITEM 1. BUSINESS
      ITEM 2. PROPERTIES
      ITEM 3. LEGAL PROCEEDINGS
      ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
    PART II.
      ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED ...
      ITEM 6. SELECTED FINANCIAL DATA
        INCOME STATEMENT
        BALANCE SHEET
      ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
        RESULTS OF OPERATIONS
        LIQUIDITY AND CAPITAL RESOURCES
      ITEM 7A. QUANTITATIVE AND QUALIITATIVE DISCLOSURE ABOUT ...
      ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
          INCOME STATEMENT
          INCOME STATEMENT
      ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ...
      ITEM 9A. CONTROLS AND PROCEDURES
      ITEM 9B. OTHER INFORMATION
    PART III
      ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
      ITEM 11. EXECUTIVE COMPENSATION
      ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND ...
      ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND ...
      ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
    PART IV
      ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
    Reports of Independent Registered Public Accounting Firms
    SIGNATURES
  EXHIBIT 10.35
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGIDTERED PUBLIC ACCOUNTANTS
  EXHIBIT 31.1
    CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.